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Free and Protein-Bound Cobalamin Absorption in Healthy 
Middle-aged and Older Subjects
Dieneke Z. van Asselt, MD /  Wim J. van den Broek, BS,f Cornelis B. Lamers, M D, P h D /  
Frans H. Corstens, MD, P h D / and Willibrord H. Hoefnagels, MD, PhD *
OBJECTIVE: To study free- and protein-bound cobalamin 
absorption and the correlation with atrophic gastritis in 
healthy middle-aged and older subjects.
DESIGN: A cross-sectional study.
PARTICIPANTS: Fifty-two healthy subjects, aged 26 to 87 
years, apparently free from conditions known to influence the 
cobalamin status. Middle-aged subjects were defined as those 
younger than 65 years of age (median age 57 years) and older 
subjects as those 65 years and older (median age 75 years).
MEASUREMENTS: Protein-bound cobalamin absorption 
was assessed by 48-hour urinary excretion method following 
oral administration of scrambled egg yolk, labeled in vivo 
with 57Co-cobalamin by injecting a hen with 57Co~cyanoco- 
balamin. The percentage of S7Co-cobalamin bound to pro­
tein was 65%. Free cobalamin absorption was assessed by 
48-hour urinary excretion method following oral administra­
tion of crystalline 57Co-cyanocobalamin. Plasma cobalamin, 
folate and fasting plasma gastrin, and pepsinogen A and C 
concentrations were determined.
RESULTS: The median urinary excretion of egg yolk 57Co~ 
cobalamin in middle-aged subjects was 12.3% (25th and
75th percentiles 10.5%-14.5%) compared with 11.7% (25th 
and 75th percentiles 9.8%-13.6%) in older subjects (P = 
.283). The median urinary excretion after administration of 
free 57Co-cobalamin in middle-aged subjects was 25.7% 
(25th and 75th percentiles 20.6% -30.7%) compared with 
27.9% (25th and 75th percentiles 21.4%-34.5%) in older 
subjects (P = .694). Neither egg yolk nor free 57Co- 
cobalamin excretion correlated with age.
A ratio of pepsinogen A to pepsinogen C less than 1.6, 
indicating atrophic gastritis, was found in 13 subjects. Within 
the atrophic gastritis group, 11 subjects had a pepsinogen A 
concentration greater than or equal to 17 jug/L, indicating 
mild to moderate atrophic gastritis, and two subjects had a 
pepsinogen A concentration less than '17 jug/L, indicating 
severe atrophic gastritis or gastric atrophy. All subjects had 
normal fasting plasma gastrin concentrations. Free and egg
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yolk 57Co-cobalamin excretions were not reduced in the 
atrophic gastritis group when compared with the non- 
atrophic gastritis group.
Median plasma cobalamin concentration was not signifi­
cantly lower in older subjects (P =  -205). Nonetheless, 
plasma cobalamin concentration correlated negatively with
age (r =  -.36; P = .008).
CONCLUSIONS: We demonstrated no significant difference 
in either free or protein-bound cobalamin absorption be­
tween healthy middle-aged and older adults. In addition, no 
alteration in cobalamin absorption was found in subjects 
identified as having mild to moderate atrophic gastritis. 
Therefore, based on our results, the high prevalence of low 
cobalamin levels in older people cannot be explained by 
either the aging process or mild to moderate atrophic gastri­
tis. J Am Geriatr Soc 44:949-953, 1996.
M any investigators have reported on the strikingly in­
creased prevalence of low serum cobalamin concentra­
tions in older people.1"6 Recent studies have presented evi­
dence that these low serum cobalamin levels, in most cases, 
reflect tissue cobalamin deficiency,6,7 Moreover, it has been 
recognized that cobalamin treatment of patients with low 
serum cobalamin levels, but without the classical features of 
deficiency, may correct a number of subtle metabolic, neuro­
logical, and psychiatric abnormalities.8 Therefore, it is of 
special interest to investigate the underlying mechanism of 
the low serum cobalamin levels found frequently in older 
people. Several pathophysiological possibilities can come 
into consideration. Dietary causes generally do not play an 
important role.9 In addition, the intestinal absorption of free 
cobalamin, as measured by the classical Schilling test, is 
usually not decreased in older patients with low cobalamin 
levels.10"15 Recently, however, low cobalamin levels have 
been related to protein-bound or food cobalamin malabsorp­
tion.12,16' 18 Protein-bound cobalamin malabsorption is 
thought to result from an impaired release of cobalamin from 
its binders in food, because of reduced gastric acid secretion, 
in the presence of adequate intrinsic factor secretion.19”22 
Indeed, subjects with a- or hypochlorhydria, most commonly 
caused by atrophic gastritis, have lower serum cobalamin 
levels.23 Since the prevalence of atrophic gastritis increases 
with age, it has been hypothesized that low serum cobalamin 
levels in older people are the result of decreased protein- 
bound malabsorption caused by atrophic gastritis. However, 
as yet, only a few studies (and with conflicting results), have
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specifically addressed this question.16"18,24 Therefore, we car­
ried out a study on cobalamin absorption, both free and 
protein-bound, and its relation to atrophic gastritis in healthy 
middle-aged and older subjects. We used scrambled egg yollc 
labeled in vivo with 57Co-cobalamin to investigate the pro­
tein-bound cobalamin absorption.25 We selected this test 
meal because in vivo labeling, as opposed to in vitro labeling, 
ensures that 57Co-cobalamin is bound naturally to its specific 
binders. Furthermore, scrambled egg yolk, when compared 
with raw chicken serum, is a commonly used food. We 
demonstrate that free and protein-bound cobalamin absorp­
tion in healthy volunteers are not affected by either age or 
mild to moderate atrophic gastritis.
METHODS
Preparation o f Protein-Bound S7Co-Cob alamin
On three consecutive days, 250 kBq 57Co-cyanocobaI- 
amin (Kodak Clinical Diagnostics LTD, Amersham) was 
injected into the breast of an egg-laying hen (in total 750 
kBq = 20 /xCi). Radioactivity in eggs was detected 1 or 2 days 
after the first injection, reaching peak activity at days 6 to 8. 
Eggs numbered 2 to 16 had a total activity of 300 kBq 
57Co~cobalamin. Yolks were separated from the egg whites. 
Because no radioactivity was recovered in egg whites, only 
yolks were used to prepare the test meal. The yolks were 
homogenized and fried in a pan under constant stirring 
(scrambled) until a medium dry texture was obtained. Twelve 
to fourteen portions of about 12 g each, containing approx­
imately 18 kBq (0.5 /xCi) 57Co-cobalamin, were packaged in 
plastic containers and stored in a freezer at — 20°C until 
served. The amount of radioactivity was measured for each 
egg portion.
Assessment o f  Protein-Binding in Rato and Fried Egg Yolk
Thin layer chromatography was performed with raw in 
vivo labeled egg yolk and free 57Co-cyanocobalamin on silica 
gel impregnated glass fiber sheets (Gelman Sciences, Michi­
gan) using 0.15 M acetate buffer, pH 6.0. The sheet was cut 
into marked 1-cm segments, which were counted for radio­
activity in a sodium-iodide well crystal.
To determine the effect of heat on protein binding, 1 g of 
raw and 1 g of scrambled in vivo labeled egg yolk were 
homogenized in a blender with 20 mL of 0.15 M acetate 
buffer and subsequently centrifuged at 15.000 g for 30 min­
utes at room temperature. The same procedure was per­
formed after defrosting and heating frozen scrambled egg 
yolk for 30 seconds in a microwave oven (power 1300 W). 
Radioactivity was counted in the residue and supernatant 
and expressed as percentages of the radioactivity in the whole 
sample. All the above procedures were performed for two 
different samples of egg yolk from different batches.
Serological Measurements
Assays of plasma cobalamin, plasma folate, and folate in 
erythrocyte were performed by competitive radioisotope 
binding techniques using purified hog intrinsic factor as the 
cobalamin binder and purified jS-lactoglobulin as the folate 
binder (Solid Phase Boil DualCount, Diagnostic Products 
Corporation, Los Angeles, CA).
Plasma samples were collected from fasted subjects and 
stored at — 70°C. Fasting plasma gastrin was measured by 
radioimmunoassay,26 reference range 10-70 pmol/L. Plasma
pepsinogen A and pepsinogen C concentration were mea­
sured by sensitive and specific radioimmunoassays.27 The 
reference range for pepsinogen A is 17 to 120 /xg/L, for 
pepsinogen C, 1 to 40 /xg/L, and for the ratio of pepsinogen A 
to pepsinogen C, greater than 1.6.
Protocol
On the test day a portion of frozen scrambled egg yolk 
was defrosted and heated in a microwave oven for 30 seconds 
and served to the overnight-fasting subject for oral consump­
tion. No food was allowed for the next 2 hours. Nonradio­
active cyanocobalamin (Pharmachemie B.V. Haarlem Hol­
land OPG Groep) was administered in a dose of 1 mg by 
intramuscular injection at t = 0 h and t = 24 h. Subjects 
collected urine from t = 0 h to t = 48 h.
The volumes of the urine collections were measured. In 
an 800-mL specimen from each 24-hour collection, radioac­
tivity was counted for 1 minute on a well shielded sodium- 
iodide crystal. This was compared, under identical geometric 
conditions, with radioactivity of a freshly made, known 
57Co-standard. The urinary excretion of 57Co-cobalamin 
was expressed as a percentage of the administered dose.
Measurement of free cobalamin absorption was per­
formed after oral administration of a capsule containing 0.5 
¡ACi (0.5-1 jicg) free or crystalline 57Co-cyanocobalamin 
(Mallinckrodt Medical, Inc. St. Louis, MO) to the overnight- 
fasting subject. Subsequently, the same procedure as de­
scribed for the protein-bound cobalamin absorption test was 
followed. We were unable to test free cobalamin absorption 
in three younger subjects.
In all subjects the free cobalamin absorption test was 
performed at least 1 week after the egg yolk cobalamin 
absorption test. Pre-test urine specimens were all checked for 
radioactivity. Urinary creatinine excretions (mmol/24 hours) 
were measured to check for complete urine collection. Based 
on low urinary creatinine concentrations, incomplete collec­
tion was suspected in three absorption tests. However, the 
results of these tests were similar to the rest.
Subjects
The study protocol was approved by the Committee for 
Experimental Research with Humans of the University Hos­
pital Nijmegen. All subjects gave written informed consent.
Healthy volunteers were recruited from the general pop­
ulation by means of advertisements in local newspapers. All 
participants were asked about their medical history, current 
medication, and alcohol use and underwent physical and 
laboratory examinations. The foliowin'g exclusion criteria 
were applied: inability to comply with the protocol for urine 
collection (incontinence, cognitive impairment, impaired re­
nal function (serum creatinine > 1 2 0  &mol/L)); pregnancy; 
vegetarianism; liver disease; alcoholism; previous stomach or 
intestinal surgery; intestinal diseases; chronic diarrhea; unex­
plained loss of weight; anemia; cobalamin or folate deficiency 
in the past, and ongoing treatment with cobalamin, folic acid, 
oral contraceptives, antacids, antibiotics, chloral hydrate, 
vitamin C, anticonvulsants, metformin, potassium salt, or 
colestyramine. The subjects lived at home, were self-sufficient 
and fully ambulant, and had no current illness. All subjects 
had normal hemoglobin, serum creatinine, ALAT, serum 
albumin, and serum iron concentrations. One older male 
subject had a mean cell volume of 105 fl; he had normal 
cobalamin and folate concentrations.
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Figure 1. Thin layer chromatography of in vivo 57Co-labeled raw 
egg yolk (•—•) and free 57Co-cyanocobalamin (■ — ■). Measured 
radioactivity is plotted against the distance on the sheet.
Statistical Analysis
The results are presented as medians with the 25th and 
75th percentiles. The Wilcoxon Rank Sum Test was used for 
comparing continuous variables of unpaired samples. Confi­
dence intervals for differences in the mean were calculated. 
The Wilcoxon Signed Rank Test was used for comparing 
continuous variables of paired samples. The chi-square test 
was used to assess dependence between categorical variables. 
The relation between two continuous variables was studied 
with the Spearman correlation coefficient. A P value of .05 or 
less was considered significant.
RESULTS
Protein-Binding and the Effect o f Heating
The results of thin layer chromatography of raw in vivo 
labeled egg yolk and free 57Co~cyanocobalamin are shown in 
Figure 1. Most radioactivity of in vivo labeled raw egg yolk 
was recovered on the first segments of the sheet. In contrast 
all radioactivity of free 57Co-cyanocobalamin was recovered 
at the end of the sheet. Radioactivity in the residue of raw egg 
yolk was 92%. Radioactivity in the residue of scrambled egg 
yolk was 65%. Defrosting and heating of the frozen scram­
bled egg yolk meal in the microwave oven for 30 seconds did 
not alter this percentage.
Subjects
Fifty-two subjects were included in the study (Table 1). 
The subjects were divided into two groups: those younger
than 65 years (middle-aged subjects, median age 57 years, 
range 26 to 65 years, n =  24) and those 65 years and older 
(older subjects, median age 75 years, range 66 to 87 years, 
= 28).n
Median plasma cobalamin concentration was lower in 
older subjects, although statistical significance was not 
reached (P =  .205). Nonetheless, plasma cobalamin concen­
tration correlated negatively with age (Spearman r = — .36; 
P =  .008; n =  52). The relationship between plasma cobal­
amin concentrations (y) and age (x) is given by the equation 
y =  339-1.5x. Accordingly, the estimated decline in plasma 
cobalamin concentrations per year is 1.5 pmol/L.
The ratio of pepsinogen A to pepsinogen C was less than 
1.6, indicating atrophic gastritis, in 13 subjects, 8 of whom 
were 65 years or older. In the atrophic gastritis group, 11 
subjects had a pepsinogen A concentration equal to or greater 
than 17 /xg/L, indicating mild to moderate atrophic gastritis. 
Two subjects had a pepsinogen A concentration less than 17 
¿¿g/L, indicating severe atrophic gastritis or gastric atrophy. 
The atrophic gastritis group had significantly higher plasma 
gastrin levels (P = .026). However, all subjects had normal 
(less than 70 pmol/L) fasting plasma gastrin levels. The ratio 
of pepsinogen A to pepsinogen C did not correlate with age or 
plasma cobalamin levels.
Egg Yolk and Free Cobalamin Absorption Test Results
The results of the egg yolk and free cobalamin absorp­
tion tests are presented in Table 2. The median urinary 
excretion of 57Co-cobalamin after administration of egg yolk 
cobalamin was 12.3% in middle-aged subjects and 11.7% in 
older subjects (P =  .283), The 95% confidence interval for 
the difference in mean egg yolk 57Co-cobalamin excretion 
between middle-aged (12.9 ±  3.2, mean ±  SD) and older 
subjects (12.1 ± 3.1, mean ±  SD) was —0.958 to 2.558. The
median urinary excretion of 57Co-cobalamin following the 
oral administration of free cobalamin was 25.7% in middle- 
aged subjects and 27.9%  in older subjects (P = .694). The 
95 % confidence interval for the difference in mean free 57Co- 
cobalamin excretion between the middle-aged (26.1 ±  7.2, 
mean ± SD) and older subjects (27.1 ± 7.5, mean ± SD) was 
—5.282 to 3.282. The scatterplot showed no relation be­
tween the urinary excretion of 57Co~cobalamin in both ab­
sorption tests and age. Furthermore, neither egg yolk nor free 
57Co-cobalamin excretion correlated with age. No correla­
tions could be demonstrated between the 57Co-excretion on
Table 1. Clinical and Laboratory Characteristics of Healthy Middle-Aged and Older Subjects*
Middle-Aged Subjects Older Subjects P Value
Sex (female/male) 12/12 13/15 .797
Age (y) 57 (39-62) 75 (69-78)
Plasma cobalamin (pmol/L) 250 (190-300) 220 (170-280) .205
P-folate (nmol/L) 14 (11 -24) 15 (12-17) .883
E-folate (nmol/L) 565 (500-650) 565 (420-780) .783
Plasma gastrin (pmol/L) 20 (14-37) 19(16-25) .785
Plasma PG A (/xg/L) 30 (26-51) 47 (38-60) .067
Plasma PG C (/xg/L) ( 14(10-25) 18(14-25) .228
PG A/C ratio 2.9 (1.6-3.1) 2.9 (1.3-3.3) .824
* Results in number of subjects or median and 25th and 75th percentiles (in brackets). 
Abbreviations: P-folate, plasma folate; E-folate, folate in erytrocytes; PG, pepsinogen.
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Table 2. Results of the Egg Yolk and Free Cobalamin Absorption Tests by 24-Hour Periods'*'’
Middle-Aged Subjects Older Subjects P Value
Egg yolk cobalamin absorption (%) n = 24 n -  28
First 24-hour period 8.4 (7.2-9.8) 7.8 (6.4-9.4) .409
Second 24-hour period 4.2 (3.3-5.1) 3.8 (3.0-4.5) .308
Total 48-hour period 12.3 (10.5-14.5) 11.7(9.8-13.6) .283
Free cobalamin absorption (%) n = 21 n = 28
First 24-hour period 17.2 (12.9-21.0) 18.5 (14.9-23.6) .342
Second 24-hour period 8.0 (6.7-10.7) 8.8 (5.7-10.0) .832
Total 48-hour period 25.7 (20.6-30.7) 27.9 (21.4-34.5) .694
* Results in median and 25 th and 75 th percentiles (in brackets).
the one hand and plasma cobalamin, gastrin and ratio of 
pepsinogen A to pepsinogen C on the other. No significant 
difference between men and women could be demonstrated.
The median egg yolk 57Co-cobalamin exci*etion in 13 
subjects with atrophic gastritis was 12.1% (25th and 75th 
percentiles 9.8%-14.7%) compared with 11,9% (25th and 
75th percentiles 10.2%-14.2%) in the non-atrophic gastritis 
group (P = .892). The median free 57Co-cobalamin excretion 
in the atrophic gastritis group was 26.7% (25th and 75th 
percentiles 21.5%-34.4%) compared with 27.0% (25th and 
75th percentiles 19.9%-26.7%) in the non-atrophic gastritis 
group (P = .695). The results of the egg yolk cobalamin 
absorption test in two older subjects with severe atrophic 
gastritis were 9.9% and 13.7%. Both subjects had normal 
plasma gastrin concentrations. The ratio of pepsinogen A to 
pepsinogen C did not correlate with free or egg yolk 57Co~ 
cobalamin excretion.
DISCUSSION
Investigators have hypothesized that the high prevalence 
of reduced serum cobalamin levels in older people is the result 
of decreased protein-bound cobalamin absorption attribut­
able to an age-related increase in atrophic gastritis. In this 
study, we have demonstrated that plasma cobalamin levels 
decreased with advancing age in healthy middle-aged and 
older adults whereas neither free nor protein-bound cobal­
amin absorption was significantly affected by either age or 
mild to moderate atrophic gastritis. Our finding that free 
cobalamin absorption does not decline with age is in agree­
ment with previous reports.29,30 However, in literature there 
is at present no consensus on protein-bound cobalamin mal­
absorption as a cause for the increased number of older 
people with low serum cobalamin levels. To explain the 
divergent findings, one has to take into account several fac­
tors related either to the ‘test-meaP conditions or to the 
prevalence and severity of atrophic gastritis in the study 
populations.
Many variations of the protein-bound absorption test 
have been described, from raw in vitro labeled chicken serum 
to cooked in vivo labeled trout. The test-meals differ in a 
number of elements that are known to influence the protein- 
bound cobalamin absorption: cobalamin binders, cobalamin 
form, degree of protein-binding, preparation (i.e., fried, 
cooked, boiled etc.), and volume. In the present investigation, 
scrambled egg yolk labeled in vivo with 57Co-cobalamin was 
used. We selected this test meal because in vivo labeling, 
rather than in vitro labeling, ensures that 57Co-cobalamin is
bound naturally to its specific binders. Furthermore, sci’am- 
bled egg yolk, when compared with raw chicken serum, is a 
commonly used food. However, the degree of protein- 
binding in our test meal decreased from 92% to 65% after 
scrambling. Therefore, a higher amount of free 57Co- 
cobalamin may well have contributed to higher absorption 
percentages compared with test meals that are not heated. 
Nonetheless, we deliberately decided to heat our test-meal 
because most foods containing cobalamin — liver, meat, and 
eggs — are heated before consumption. Furthermore, admin­
istration of raw chicken material to older people was consid­
ered ethically unjust in view of a possible contamination of 
the test meal with Salmonella. In sum, the absorption of 
protein-bound cobalamin varies with the test-meal, and no 
consensus exist on the specific demands for a test-meal as an 
appropriate model for the effect of protein-binding on cobal­
amin absorption. Therefore, standardization of the protein- 
bound cobalamin absorption test seems warranted to render 
future studies comparable.
Atrophic gastritis is frequently considered to be the likely 
mechanism of protein-bound cobalamin malabsorption. We 
assessed the presence and severity of atrophic gastritis indirectly 
by serological measurements of plasma pepsinogen A and pep­
sinogen C. The determination of the ratio of pepsinogen A to 
pepsinogen C is considered a “serological biopsy” of the gastric 
fundic mucosa since a good correlation has been reported be­
tween the histologic and functional status of the stomach on the 
one hand and the pepsinogen concentrations on the other.31 
Thus, we found that the cobalamin absorption from scrambled 
egg yolk in healthy subjects was not affected by mild to moderate 
atrophic gastritis. Therefore, protein-bound cobalamin malab­
sorption attributable to mild to moderate atrophic gastritis 
seems a less likely explanation for the reduced cobalamin levels 
in older people. It is possible that the release of cobalamin from 
its protein-binders by gastric acid and/or pepsin is not com­
pletely impaired in subjects with milder forms of atrophic gas­
tritis. However, not all subjects with a- or hypochlorhydria have 
protein-bound cobalamin malabsorption, and not all subjects 
with this malabsorption have gastric dysfunction.18,24 These 
observations suggest that several other conditions are probably 
involved in determining protein-bound cobalamin malabsorp­
tion, such as bacterial overgrowth,32 Helicobacter pylori infec­
tion,33 or secretory pancreatic abnormalities.34 To summarize, 
the relative importance of acid-pepsin digestion for the release of 
cobalamin from its binders remains to be established.
Our finding that protein-bound cobalamin absorption is 
not related to age is in agreement with Jones et al.17 and Carmel
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et al.18 In contrast, Dawson et al.16 reported reduced protein- 
bound cobalamin absorption in older patients when compared 
with younger volunteers. However, a small number of subjects 
were studied, and statistical significance was not reached. A 
significant decline in protein-bound cobalamin absorption was 
reported by Scarlett et al.,24 though their subjects were older 
than the volunteers in the present investigation (mean age of 
their middle-aged subjects was 64 years and of the older subjects, 
83 years). In addition, many of their subjects older than age 55 
years probably had severe atrophic gastritis since almost half 
had elevated serum gastrin levels. Therefore, the age effect on 
protein-bound cobalamin absorption observed in the study by 
Scarlett and co-workers,24 but not in the present study, may 
reflect a difference in the prevalence and severity of atrophic 
gastritis in the study populations. In the five studies, including 
the present investigation, that have addressed the relation be­
tween age and protein-bound cobalamin absorption, four differ­
ent test-meals were used. Jones et al.17 and Dawson et al.16 used 
in vitro labeled chicken serum. Carmel et al.18 used scrambled in 
vitro labeled egg yolk, and Scarlett et al 24 administered raw in 
vitro labeled whole egg mixed with '150 mL of milk. It is possible 
diat age has a distinct influence on cobalamin absorption as 
measured by these different test-meals. Since cobalamin absorp­
tion differs with each of these meals it is also possible that the 
influence of age varies. It would, therefore, be of interest to study 
the effect of age on protein-bound cobalamin absorption by 
administering different test meals to each participant.
In conclusion, based on our results, the high prevalence 
of low cobalamin levels in older people cannot be explained 
either by the aging process or by mild to moderate atrophic 
gastritis. On the other hand, we can not rule out the effect of 
severe atrophic gastritis. Indeed, Krasinski et al.35 have dem­
onstrated that the minority of older people with atrophic 
gastritis have low serum cobalamin levels, whereas the ma­
jority of older people with low serum cobalamin levels have 
severe atrophic gastritis. To explain the observed age-related 
decline in plasma cobalamin levels in the present study, 
additional influences on the cobalamin status have to be 
taken into consideration. For example, the intake of cobal­
amin with different (prepared) foods, the time elapsed from 
the onset of atrophic gastritis, the functional and structural 
integrity of the serum cobalamin binding-proteins, and, fi­
nally, the amount of cobalamin stored in the liver.
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